Skip to main content
Signal8

Lehrer-Graiwer Joshua

SEC insider (Form 3/4/5 filer). CIK 0001789673. President & COO at LISATA THERAPEUTICS, INC. (LSTA) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 23, 2026. Located in LIBERTY CORNER, NJ.

Companies Lehrer-Graiwer Joshua has filed insider reports for

  • LISATA THERAPEUTICS, INC. (LSTA): Officer, President & COO
  • Fulcrum Therapeutics, Inc. (FULC): Director
Lehrer-Graiwer Joshua profile photo

Lehrer-Graiwer Joshua

CIK: 0001789673

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LISATA THERAPEUTICS, INC. logo
LSTA

LISATA THERAPEUTICS, INC.

Officer
Fulcrum Therapeutics, Inc. logo
FULC

Fulcrum Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Fulcrum Therapeutics, Inc. logo
    FULC

    Fulcrum Therapeutics, Inc.

    Apr 23, 2026
    Award

    Stock Option (right to buy)

    Direct
    64K shares-

1-1 of 1